Anand, Inder
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Article History
First Online: 14 May 2018
Compliance with Ethical Standards
:
: Technical assistance with editing and styling of the manuscript for submission was provided by Oxford PharmaGenesis Inc., Newtown, Pennsylvania, USA, and was funded by Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
: The author was fully responsible for all content and editorial decisions and received no financial support or other form of compensation related to the development of this manuscript. Dr. Anand is a consultant to, and has received honoraria from, Amgen, Arca, AstraZeneca, Boehringer Ingelheim, Cyberonics, and Zensun.
: This article does not contain any studies with human participants performed by the author.